NCT04180150 - A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

December 31, 2021

Conditions

Chronic Hepatitis B

Interventions

DRUG

TQ-A3334

TQ-A3334 is a kind of TLR7 receptor agonist.

DRUG

Placebo

Placebo is a treatment which is designed to have no therapeutic value.

DRUG

Entecavir Tablet

Entecavir (ETV) tablet is an antiviral medication used in the treatment of hepatitis B virus (HBV) infection.

Trial Locations (2)

NOT_YET_RECRUITING

The second affiliated hospital of chongqing medical university, Chongqing

RECRUITING

The first hospital of Jilin University, Changchun